Skip to main content

Table 2 Clinical features and laboratory values of children with MPP between the PB group and the non-PB group

From: Clinical features and risk factors of plastic bronchitis caused by Mycoplasma pneumoniae pneumonia in children

Characteristic

Total

N = 1169

PB

N = 133

non-PB

N = 1036

χ²

P value

Clinical data

     
 

Time from illness onset to admission (days)

8.00 (6.00, 10.00)

7.00 (6.00, 9.00)

8.00 (6.00, 10.00)

1.7263

0.1889

 

Duration of hospitalization (days)

7.00 (6.00, 9.00)

9.00 (8.00, 10.00)

7.00 (6.00, 8.00)

101.5953

< 0.0001*

 

Duration of fever (days)

7.00 (5.00, 9.00)

7.00 (5.00, 8.00)

7.00 (5.00, 9.00)

0.0144

0.9046

 

Duration of cough (days)

7.00 (5.00, 9.00)

7.00 (5.00, 9.00)

7.00 (5.00, 9.00)

1.0771

0.2993

 

Fatigue

12 (1.03)

1 (0.75)

11 (1.06)

-

1

 

Dyspnea

17 (1.45)

2 (1.50)

15 (1.45)

 

1

 

Wheezing

46 (3.93)

4 (3.01)

42 (4.05)

-

0.8120

 

Lack of appetite

714 (61.08)

98 (73.68)

616 (59.46)

-

0.0013*

 

Abdominal pain

201 (17.19)

26 (19.55)

175 (16.89)

-

0.4653

 

Diarrhea

75 (6.42)

10 (7.52)

65 (6.27)

-

0.5720

 

Chest pain

33 (2.82)

3 (2.26)

30 (2.90)

-

1

Physical sign

     
 

Decreased breath sounds

700 (59.88)

93 (69.92)

607 (58.59)

-

0.0088*

 

Rales

773 (66.12)

81 (60.90)

692 (66.80)

-

0.1461

 

Rhonchi

334 (28.57)

35 (26.32)

299 (28.86)

-

0.5430

 

Tachypnea

39 (3.34)

6 (4.51)

33 (3.19)

-

0.4387

 

Hypoxia

40 (3.42)

6 (4.51)

34 (3.28)

-

0.4472

 

Three depressions sign

20 (1.71)

4 (3.01)

16 (1.54)

-

0.2733

Laboratory findings

     
 

WBC (×109/L)

8.12 (6.45, 10.22)

7.74 (6.29, 10.22)

8.15 (6.49, 10.24)

1.0187

0.3128

 

 N (×109/L)

4.65 (3.43, 6.31)

5.12 (4.01, 7.00)

4.59 (3.36, 6.21)

8.9667

0.0027*

 

L (×109/L)

2.37 (1.67, 3.27)

1.70 (1.21, 2.40)

2.47 (1.79, 3.37)

58.0923

< 0.0001*

 

PLT (×109/L)

312.00 (252.00, 387.00)

288.50 (232.00, 336.00)

316.00 (256.00, 393.00)

16.3478

< 0.0001*

 

CRP (mg/dL)

12.10 (4.60, 25.26)

26.74 (13.29, 52.31)

10.93 (3.97,22.73)

75.6621

< 0.0001*

 

PCT (µg/L)

0.12 (0.07, 0.25)

0.25 (0.13, 0.44)

0.11 (0.07, 0.22)

46.2664

< 0.0001*

 

ESR (mm/h)

25.00 (16.00, 40.00)

27.00 (20.00, 41.00)

24.00 (15.00, 39.00)

2.8851

0.0894

 

D-dimer (mg/L)

0.64 (0.35, 1.31)

1.68 (1.04, 2.68)

0.58 (0.33, 1.09)

136.2348

< 0.0001*

 

LDH (U/L)

324.00 (271.00, 409.00)

453.00 (349.00, 567.00)

315.00 (267.00, 388.00)

100.1390

< 0.0001*

 

ALT (U/L)

13.00 (10.00, 20.60)

21.45 (14.80, 37.40)

12.60 (9.80, 19.00)

62.1271

< 0.0001*

 

AST (U/L)

25.00 (20.00, 32.00)

33.00 (26.00, 50.00)

24.00 (20.00, 30.00)

69.6598

< 0.0001*

CT scan

     
 

Consolidation

921 (78.79)

102 (76.69)

819 (79.05)

-

0.5741

 

Single lobar infiltrate

463 (39.61)

66 (49.62)

397 (38.32)

-

0.0187*

 

Multilobar infiltrates (unilateral)

330 (28.23)

26 (19.55)

304 (29.34)

-

0.0252*

 

Multilobar infiltrates (bilateral)

355 (30.37)

39 (29.32)

316 (30.50)

-

0.7657

 

Pleural effusion

210 (17.96)

51 (38.35)

159 (15.35)

-

< 0.0001*

 

Pericardial effusion

29 (2.48)

7 (5.26)

22 (2.12)

-

0.0391*

Fiberoptic bronchoscopy

     
 

Mucosal hyperemia and/or edema

711 (60.82)

32 (24.06)

679 (65.54)

-

< 0.0001*

 

Mucosal erosion and/or necrosis

458 (39.18)

101 (75.94)

357 (34.46)

-

< 0.0001*

 

Bronchial embolization

212 (18.14)

82 (61.65)

130 (12.55)

-

< 0.0001*

 

Bronchial obstruction

14 (1.20)

2 (1.50)

12 (1.16)

-

0.6688

 

Bronchiectasis

5 (0.43)

0 (0.00)

5 (0.48)

-

1

  1. Data are presented as median [IQR] and n (%). Differences between groups were determined by Kruskal-Wallis H test (median [IQR]) and Fisher’s exact test (proportions). *P <0.05